GTB-3650 TriKE for CD33 positive leukemias The ongoing Phase 1 dose escalation study is evaluating GTB-3650 for relapsed or refractory (r/r) CD33 expressing hematologic malignancies, including refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Enrollment in Cohort 4 (10 µg/kg/day) is ongoing, and the Company expects to initiate dosing in Cohort 5 (25 µg/kg/day) in Q2 2026. The Company anticipates providing the next update in the third quarter of 2026, which would include longer term f ...

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”), announces that the shareholders of the Company considered and voted at the special meeting of shareholders held on February 27, 2026 (the “Special Meeting”) to approve Uranium Energy Corp. (“Uranium Energy”) as a control person of the Company and the issuance by the Company to UEC Energy Corp. (“UEC”), a wholly-owned subsidiary of Uranium Energy, of 896, ...

Intersection includes 55.4 m of 1.96 g/t gold and 9.9 m of 3.22g/t gold Discovery of additional Gold Mineralization expands 826 Zone at Juby Additional Diamond Drill added at site TORONTO, March 02, 2026 (GLOBE NEWSWIRE) -- McFarlane Lake Mining Limited ("McFarlane" or the "Company") (CSE: MLM, OTC: MLMLF, FRA: W2Z) is pleased to announce further results from its diamond drilling exploration campaign being conducted on its 100%-owned Juby Gold Project, located west of Gowganda, Ontario, within the southern ...

Now in its seventh year, the Loblaw®–Flashfood partnership has delivered more than $295 million in savings while diverting over 105 million pounds of food from landfill nationwide. BRAMPTON, Ontario, March 02, 2026 (GLOBE NEWSWIRE) -- Loblaw® and Flashfood mark another successful year of impact, delivering meaningful savings to customers while advancing efforts to reduce food waste across Canada. Through the program, quality food nearing its best-before date ends up on tables instead of going to waste – cre ...

"The transaction makes strategic sense due to the certain liquidity provided by the premium cash consideration as well as the non-approval risk….the current offer appears to provide a reasonable outcome compared to available and likely alternatives given [the] company's current share ownership structure." ISS is a leading independent proxy voting and corporate governance advisory firm whose shareholder voting recommendations and analysis are subscribed to, and are relied upon, by many pension funds, investm ...

This contract advances REalloys' direct Sm and Gd metallothermal processing platform including revolutionary zero-waste rare earth metallization technology and positions the company as a first-mover in re-establishing U.S. commercial-scale production of Sm and Gd metals, capabilities that do not currently exist domestically. Today, global supply of these metals remains almost entirely offshore, leaving U.S. defense and industrial users exposed to geopolitical risk, long lead times, and price volatility. As ...

New research on future of bundling shows Americans turning on monthly streaming bills, calling for rewards for watching and even pay-per-minute TV CAMBRIDGE, United Kingdom, March 02, 2026 (GLOBE NEWSWIRE) -- A quarter of Americans (25%) think streaming services should introduce rewards for binge-watching "streaks", such as unlocking discounts after streaming a set number of hours or completing a season. That's according to new research from Bango (AIM: BGO). The finding comes from the newly released "The f ...

In 2024, Agios entered into a distribution agreement with NewBridge Pharmaceuticals to advance regulatory filings and commercialization of PYRUKYND in the Gulf Cooperation Council (GCC), which includes Saudi Arabia, the UAE, Kuwait, Qatar, Oman, and Bahrain. NewBridge Pharmaceuticals, a first-in-class commercialization platform for innovative therapeutics in the Middle East and North Africa, is supporting the commercial launch of PYRUKYND for thalassemia in Saudi Arabia following its approval by the Saudi F ...

Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories SUNNYVALE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the completion of its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. Important Safety Information "Intuitive is entering a new ch ...

Prof. Brown, is a psychiatrist, neurologist, and neuroscientist who studies the underlying mechanisms of Transcranial Magnetic Stimulation (TMS) and translating these mechanisms into clinical optimization. He's the Medical Director of the McLean Hospital TMS Service, the Director of TMS research, and founding director of the Brain Stimulation Mechanisms Laboratory with more than $20M awarded in federal funding from the National Institute of Mental Health and the Defense Advanced Research Projects Agency. He ...